These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 26474830)
1. Antifungal activity improved by coproduction of cyclodextrins and anabaenolysins in Cyanobacteria. Shishido TK; Jokela J; Kolehmainen CT; Fewer DP; Wahlsten M; Wang H; Rouhiainen L; Rizzi E; De Bellis G; Permi P; Sivonen K Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13669-74. PubMed ID: 26474830 [TBL] [Abstract][Full Text] [Related]
2. Alternative Biosynthetic Starter Units Enhance the Structural Diversity of Cyanobacterial Lipopeptides. Mareš J; Hájek J; Urajová P; Kust A; Jokela J; Saurav K; Galica T; Čapková K; Mattila A; Haapaniemi E; Permi P; Mysterud I; Skulberg OM; Karlsen J; Fewer DP; Sivonen K; Tønnesen HH; Hrouzek P Appl Environ Microbiol; 2019 Feb; 85(4):. PubMed ID: 30504214 [TBL] [Abstract][Full Text] [Related]
3. Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway. Vestola J; Shishido TK; Jokela J; Fewer DP; Aitio O; Permi P; Wahlsten M; Wang H; Rouhiainen L; Sivonen K Proc Natl Acad Sci U S A; 2014 May; 111(18):E1909-17. PubMed ID: 24742428 [TBL] [Abstract][Full Text] [Related]
4. Chemical diversity and cellular effects of antifungal cyclic lipopeptides from cyanobacteria. Fewer DP; Jokela J; Heinilä L; Aesoy R; Sivonen K; Galica T; Hrouzek P; Herfindal L Physiol Plant; 2021 Oct; 173(2):639-650. PubMed ID: 34145585 [TBL] [Abstract][Full Text] [Related]
8. Cyanochelins, an Overlooked Class of Widely Distributed Cyanobacterial Siderophores, Discovered by Silent Gene Cluster Awakening. Galica T; Borbone N; Mareš J; Kust A; Caso A; Esposito G; Saurav K; Hájek J; Řeháková K; Urajová P; Costantino V; Hrouzek P Appl Environ Microbiol; 2021 Aug; 87(17):e0312820. PubMed ID: 34132591 [TBL] [Abstract][Full Text] [Related]
9. Antifungal compounds from cyanobacteria. Shishido TK; Humisto A; Jokela J; Liu L; Wahlsten M; Tamrakar A; Fewer DP; Permi P; Andreote AP; Fiore MF; Sivonen K Mar Drugs; 2015 Apr; 13(4):2124-40. PubMed ID: 25871291 [TBL] [Abstract][Full Text] [Related]
10. Structure and biosynthesis of heat-stable antifungal factor (HSAF), a broad-spectrum antimycotic with a novel mode of action. Yu F; Zaleta-Rivera K; Zhu X; Huffman J; Millet JC; Harris SD; Yuen G; Li XC; Du L Antimicrob Agents Chemother; 2007 Jan; 51(1):64-72. PubMed ID: 17074795 [TBL] [Abstract][Full Text] [Related]
11. A novel actinomycete strain de-replication approach based on the diversity of polyketide synthase and nonribosomal peptide synthetase biosynthetic pathways. Ayuso A; Clark D; González I; Salazar O; Anderson A; Genilloud O Appl Microbiol Biotechnol; 2005 Jun; 67(6):795-806. PubMed ID: 15647936 [TBL] [Abstract][Full Text] [Related]
12. Distribution and diversity of natural product genes in marine and freshwater cyanobacterial cultures and genomes. Ehrenreich IM; Waterbury JB; Webb EA Appl Environ Microbiol; 2005 Nov; 71(11):7401-13. PubMed ID: 16269782 [TBL] [Abstract][Full Text] [Related]
13. The lipopeptide toxins anabaenolysin A and B target biological membranes in a cholesterol-dependent manner. Oftedal L; Myhren L; Jokela J; Gausdal G; Sivonen K; Døskeland SO; Herfindal L Biochim Biophys Acta; 2012 Dec; 1818(12):3000-9. PubMed ID: 22842546 [TBL] [Abstract][Full Text] [Related]
14. Characterization of biosynthetic gene cluster for the production of virginiamycin M, a streptogramin type A antibiotic, in Streptomyces virginiae. Pulsawat N; Kitani S; Nihira T Gene; 2007 May; 393(1-2):31-42. PubMed ID: 17350183 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the interaction of the antifungal and cytotoxic cyclic glycolipopeptide hassallidin with sterol-containing lipid membranes. Humisto A; Jokela J; Teigen K; Wahlsten M; Permi P; Sivonen K; Herfindal L Biochim Biophys Acta Biomembr; 2019 Aug; 1861(8):1510-1521. PubMed ID: 31226245 [TBL] [Abstract][Full Text] [Related]
16. Hassallidin A, a glycosylated lipopeptide with antifungal activity from the cyanobacterium Hassallia sp. Neuhof T; Schmieder P; Preussel K; Dieckmann R; Pham H; Bartl F; von Döhren H J Nat Prod; 2005 May; 68(5):695-700. PubMed ID: 15921412 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial, antifungal and cytotoxic activity of terrestrial cyanobacterial strains from Serbia. Svircev Z; Cetojevic-Simin D; Simeunovic J; Karaman M; Stojanovic D Sci China C Life Sci; 2008 Oct; 51(10):941-7. PubMed ID: 18815758 [TBL] [Abstract][Full Text] [Related]
18. Balticidins A-D, antifungal hassallidin-like lipopeptides from the Baltic Sea cyanobacterium Anabaena cylindrica Bio33. Bui TH; Wray V; Nimtz M; Fossen T; Preisitsch M; Schröder G; Wende K; Heiden SE; Mundt S J Nat Prod; 2014 Jun; 77(6):1287-96. PubMed ID: 24937366 [TBL] [Abstract][Full Text] [Related]
19. Coproduction of surfactin and iturin A, lipopeptides with surfactant and antifungal properties, by Bacillus subtilis. Sandrin C; Peypoux F; Michel G Biotechnol Appl Biochem; 1990 Aug; 12(4):370-5. PubMed ID: 2119191 [TBL] [Abstract][Full Text] [Related]
20. Natural Product Biosynthetic Diversity and Comparative Genomics of the Cyanobacteria. Dittmann E; Gugger M; Sivonen K; Fewer DP Trends Microbiol; 2015 Oct; 23(10):642-652. PubMed ID: 26433696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]